Intrinsic Value of S&P & Nasdaq Contact Us

Envista Holdings Corp NVST NYSE

NYSE • Healthcare • Medical - Equipment & Services • US • USD

SharesGrow Score
43/100
0/7 Pass
SharesGrow Intrinsic Value
$19.72
-28%
Analyst Price Target
$27.22
-0.6%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Envista Holdings Corp (NVST) trades at a trailing P/E of 92.1, forward P/E of 19.4. Trailing earnings yield is 1.09%, forward earnings yield 5.15%. PEG 0.05 (Peter Lynch undervalued ≤1.0). Graham Number is $11.02.

Criteria proven by this page:

  • VALUE (35/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 92.1).
  • Forward P/E 19.4 (down from trailing 92.1) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.05 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 1.09% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 5.15% as earnings recover.
  • Analyst consensus target $27.22 (-0.6% downside) — slight downside risk — the market may be ahead of analyst expectations.

Overall SharesGrow Score: 43/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
43/100
SG Score
View full scorecard →
VALUE
35/100
Price-to-Earnings & upside
Proven by this page
FUTURE
26/100
Analyst consensus
→ Forecast
~
PAST
50/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
65/100
→ Income
GROWTH
30/100
→ Income
INCOME
30/100
→ Income

Valuation Snapshot — NVST

Valuation Multiples
P/E (TTM)92.1
Forward P/E19.4
PEG Ratio0.05
Forward PEG0.05
P/B Ratio1.39
P/S Ratio1.59
EV/EBITDA13.6
Per Share Data
EPS (TTM)$0.29
Forward EPS (Est.)$1.41
Book Value / Share$18.89
Revenue / Share$16.54
FCF / Share$1.40
Yields & Fair Value
Earnings Yield1.09%
Forward Earnings Yield5.15%
Dividend Yield0.00%
Graham Number$11.02
SharesGrow IV$19.72 (-28%)
Analyst Target$27.22 (-0.6%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 15.9 0.00 0.00 1.55 -
2017 14.4 0.00 0.87 1.54 -
2018 18.7 -0.80 0.90 1.52 -
2019 18.6 -0.74 1.14 1.77 -
2020 161.7 -2.02 1.45 2.79 -
2021 21.3 0.04 1.79 2.90 -
2022 22.6 -2.16 1.30 2.13 -
2023 -40.1 0.28 0.96 1.56 -
2024 -3.0 0.00 1.13 1.32 -
2025 77.6 -0.74 1.17 1.34 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $1.76 $2.79B $272M 9.8%
2017 $1.95 $2.81B $301.1M 10.7%
2018 $1.49 $2.84B $230.7M 8.1%
2019 $1.60 $2.75B $217.6M 7.9%
2020 $0.20 $2.28B $33.3M 1.5%
2021 $1.48 $2.51B $263.5M 10.5%
2022 $1.34 $2.57B $243.1M 9.5%
2023 $-0.60 $2.57B $-100.2M -3.9%
2024 $-6.50 $2.51B $-1.12B -44.6%
2025 $0.28 $2.72B $47M 1.7%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $1.41 $1.36 – $1.44 $2.84B $2.83B – $2.86B 10
2027 $1.56 $1.52 – $1.63 $2.95B $2.92B – $3B 10
2028 $1.73 $1.17 – $2.19 $3.04B $3.04B – $3.05B 3
2029 $1.89 $1.87 – $1.92 $3.15B $3.13B – $3.19B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message